F. Islamoğlu, “Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)”, Prosp. Pharm. Sc., vol. 22, no. 4, pp. 168–187, Dec. 2024.